“Liquid elbows” due to afatinib administration

Non-small cell lung cancer adenocarcinoma in the past decade has targeted therapies as the cornerstone for therapy. In specific patients with epidermal growth factor receptor mutation have three different therapy approaches with the tyrosine kinase inhibitors: erlotinib, gefitinib and afatinib. Nowa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Porpodis, Konstantinos, Kallianos, Anastasios, Rapti, Aggeliki, Trakada, Georgia, Velentza, Lemonia, Huang, Haidong, Tsiouda, Theodora, Hohenforst-Schmidt, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5491760/
https://ncbi.nlm.nih.gov/pubmed/28702338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.06.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados